Compound Detail
CHEMBL4861622
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4861622 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BKAXDKMHGJHAJV-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
242.2
MW (Da)
2.64
ALogP
4
HBA
0
HBD
56.5
PSA (Ų)
0.72
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.68
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HeLa | IC50 | = | 2100.0 | nM | 5.68 | Antiproliferative activity against human HeLa cells assessed as reduction in cel... | 34333396 |
| A549 | IC50 | = | 2740.0 | nM | 5.56 | Antiproliferative activity against human A549 cells assessed as reduction in cel... | 34333396 |
| U-937 | IC50 | = | 3260.0 | nM | 5.49 | Antiproliferative activity against human U-937 cells assessed as reduction in ce... | 34333396 |
| HepG2 | IC50 | = | 4750.0 | nM | 5.32 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 34333396 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34333396 | 10.1016/j.ejmech.2021.113708 | HepG2 | 1 |
| 34333396 | 10.1016/j.ejmech.2021.113708 | HeLa | 1 |
| 34333396 | 10.1016/j.ejmech.2021.113708 | MCF7 | 1 |
| 34333396 | 10.1016/j.ejmech.2021.113708 | MGC-803 | 1 |
| 34333396 | 10.1016/j.ejmech.2021.113708 | U-937 | 1 |
| 34333396 | 10.1016/j.ejmech.2021.113708 | A549 | 1 |
Data from ChEMBL 36 via Core Engine